WallStreetZenWallStreetZen

NASDAQ: ATOS
Atossa Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ATOS earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$30.1M
Current Profit Margin
0%

ATOS Return on Equity

Current Company
-29.5%
Current Industry
-63.5%
Current Market
188%
ATOS's Return on Equity (-29.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ATOS announces earnings.

ATOS Return on Assets

Current Company
-28.5%
Current Industry
2.9%
ATOS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ATOS Return on Capital Employed

Current Company
-33.06%
Current Industry
19.5%
ATOS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATOS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ATOS$0.00-$30.07M-$30.09MN/AN/A
VERU$15.93M-$62.11M-$64.59M-4.11%N/A
GLSI$0.00-$8.89M-$8.89MN/AN/A
CGEN$33.46MN/A-$18.75M+13.45%N/A
IVA$25.18M-$109.06M-$120.03M+24.86%N/A
View Top Biotech Stocks

ATOS earnings dates

Next earnings date
May 13, 2024

Atossa Therapeutics Earnings & Revenue FAQ

What were ATOS's earnings last quarter?

On Invalid Date, Atossa Therapeutics (NASDAQ: ATOS) reported Q4 2023 earnings per share (EPS) of -$0.06, up 0% year over year. Total Atossa Therapeutics earnings for the quarter were -$7.75 million. In the same quarter last year, Atossa Therapeutics's earnings per share (EPS) was -$0.06.

If you're new to stock investing, here's how to buy Atossa Therapeutics stock.

What was ATOS's earnings growth in the past year?

As of Q2 2024, Atossa Therapeutics's earnings has grown year over year. Atossa Therapeutics's earnings in the past year totalled -$30.09 million.

What is ATOS's earnings date?

Atossa Therapeutics's earnings date is Invalid Date. Add ATOS to your watchlist to be reminded of ATOS's next earnings announcement.

What was ATOS's revenue last quarter?

On Invalid Date, Atossa Therapeutics (NASDAQ: ATOS) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Atossa Therapeutics's revenue was $0.00.

What was ATOS's revenue growth in the past year?

As of Q2 2024, Atossa Therapeutics's revenue has grown null year over year. Atossa Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.